Fusion IP

Contact
fusionip.co.uk
+441142755555

Fusion IP plc

The Bioincubator, 40 Leavygreave Road
S3 7RD Sheffield
United Kingdom
+441142755555
fusionip.co.uk
Contact
Profile News
Contact

About Fusion IP

Biofusion owns the rights to 100% of the university-owned research generated at two of the UK's leading universities – The University of Sheffield and Cardiff University. These exclusive partnerships enable us to invest in some the world's most advanced and exciting science, turning world class research into business through the creation of a growing portfolio of companies, in fields as varied as drug discovery, alternative energy and engineering.

Read more about Fusion IP
Facts about Fusion IP
  • Focus : Manufacturer
  • Industry : Environmental Technology

News about Fusion IP

Fusion IP

02-Feb-2007 | business & finance

Biofusion Launches Absynth Biologics to Focus on New Treatments for MRSA infection

Biofusion plc, the university IP commercialisation company, announced the launch of a new portfolio company, Absynth Biologics Ltd, which will develop ...

Read news
Fusion IP

13-Oct-2006 | business & finance

Diurnal announces collaboration partner Phoqus to progress

Biofusion plc announced that Phoqus Group plc intends to raise approximately £3 million, gross of expenses to progress Chronocort into Phase II clinical ...

Read news
Fusion IP

04-Sep-2006 | business & finance

Axordia Participation in EUR12 Million EU Human Embryonic Stem Cell Consortium

Axordia Ltd announced its participation in the European Commission "ESTOOLS" programme. ESTOOLS is a EUR12 million stem cell research initiative that shall ...

Read news
Fusion IP

16-May-2006 | business & finance

Asterion Raises £355k Funding to Progress Novel Therapies for Hormone Related Diseases

Biofusion plc announced that its portfolio company Asterion Ltd, the Sheffield-based drug development company has raised £355k to progress its novel ...

Read news
Fusion IP

27-Feb-2006 | business & finance

Biofusion launches Genophrenix

Second new spin-out company to focus on developing targets and compounds to treat schizophrenia

Read news
Fusion IP

10-Feb-2006 | research and development

Dosing of children's medicine

Simcyp well placed to capitalize on House of Lords drug testing report

Read news
Fusion IP

25-Jan-2006 | business & finance

Biofusion invests in Axordia

Funding to further advance Axordia's stem cell programmes

Read news
Show more news about Fusion IP

Here you will find Fusion IP plc